Nether Broughton, United Kingdom

Stuart Robinson

This inventor holds 1 USPTO granted patent. Top assignee: Quadrant Drug Delivery Limited. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart Robinson. Retrieved from https://idiyas.com/inventor/stuart-robinson-uk2anphk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stuart Robinson

Introduction

Stuart Robinson is a notable inventor based in Nether Broughton, GB. He has made significant contributions to the field of drug delivery, particularly through his innovative patent related to inhalation therapies. His work focuses on improving the administration of therapeutic agents to enhance patient outcomes.

Latest Patents

Stuart Robinson holds a patent for a formulation for inhalation that involves microparticles. These microparticles are obtainable by spray-drying a substantially pure solution of a therapeutic agent. The formulation consists essentially of the agent, which retains its therapeutic activity when administered to the lung. In a preferred embodiment, the agent is insulin, showcasing Robinson's commitment to advancing medical treatments.

Career Highlights

Robinson is associated with Quadrant Drug Delivery Limited, where he applies his expertise in drug formulation and delivery systems. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry. His contributions have the potential to improve the quality of life for patients requiring inhalation therapies.

Collaborations

Stuart collaborates with Susan Stewart Smith, leveraging their combined expertise to drive advancements in drug delivery technologies. Their partnership exemplifies the collaborative spirit that is essential in the field of innovation.

Conclusion

Stuart Robinson's work in the development of inhalation therapies represents a significant advancement in the pharmaceutical industry. His innovative approach to drug formulation has the potential to transform patient care and improve therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…